DNA — Genentech Inc COM dna equity

Ownership history in ORBIMED CAPITAL LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which ORBIMED CAPITAL LLC reported a position in Genentech Inc COM dna equity (DNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.48% (2002 Q4)
Avg. % of fund
6.48%
First filed
2002 Q4
Last filed
2002 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2002 Q4 INITIATED 400,000 — — 6.48% $13.3M —
% of Fund (quarterly)    DNA price (monthly, adj. close)

Other funds also holding DNA

As of 2025 Q4 — sorted by position size

Anchorage Capital Group, L.L.C. 3Y 7Y 16.39% Madrona Venture Group, LLC 3Y 1.6% FORBES J M & CO LLP 3Y 7Y 0.7% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.42% Coastal Bridge Advisors, LLC 3Y 7Y 0.17% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.14% Erste Asset Management GmbH 0.14% Green Alpha Advisors, LLC 3Y 0.11% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.08% ALLEN OPERATIONS LLC 3Y 7Y 0.06%
← Back to ORBIMED CAPITAL LLC Holdings